AzTrials
AzTrials

Alcohol Use DisorderNCT06337721

Preventing Alcohol Use Disorders and Alcohol-Related Harms in Pacific Islander Young Adults

A study testing SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction) in people with Alcohol Use Disorder and Alcohol; Harmful Use, run by University of California, Riverside at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will: (1) refine and finalize the SPEAR intervention manual for preventing alcohol use disorders (AUD) and associated harms for Pacific Islander young adults; and (2) test SPEAR for efficacy by conducting a pretest-posttest randomized controlled trial (RCT). Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Alcohol Use Disorder, Alcohol; Harmful Use
What is being tested?
SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
240 participants
Where
1 siteUnited States
Study dates
Sep 2024to Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Of full or part self-reported Pacific Islander heritage;
  • Fluent (oral and reading) in English
  • For young adult participants: 18 - 30 years of age
  • Current drinking (1+ drink in past 30 days)
  • High AUD risk (AUDIT-C score # 4 for men, # 3 for women)
  • Not currently in alcohol treatment (medication, therapeutic).

Who cannot join

  • Do not meet inclusion criteria
  • Are unwilling to participate
  • Fail to provide or retracts consent
  • Reside outside the target Pacific Islander communities

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

ANDREW SUBICA, Ph.D. contact

(951) 827-0200

asubica@medsch.ucr.edu

United States1 site
  • UC Riverside

    Riverside, California, 91784

Other trials in United States

About this study

This study will: (1) refine and finalize the SPEAR intervention manual for preventing alcohol use disorders (AUD) and associated harms for Pacific Islander young adults; and (2) test SPEAR for efficacy by conducting a pretest-posttest randomized controlled trial (RCT).

Read the detailed description

Pacific Islander young adults bear elevated risk for alcohol use disorders (AUD) and alcohol-related harms, yet lack effective interventions to reduce their risk. Grounded in the social development model, this study will: (1) refine and finalize the SPEAR intervention manual for preventing alcohol use disorders (AUD) and associated harms for Pacific Islander young adults from existing evidence-based AUD prevention strategies; then (2) test SPEAR for efficacy by conducting a pretest-posttest randomized controlled trial (RCT) with at-risk Pacific Islander young adults across multiple Pacific Islander communities in the US.

Being tested
SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction)
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction)Behavioural

    This behavioral group intervention will consist of multiple group sessions to reduce AUDs and alcohol-related harms in Pacific Islander young adults. It will infuse culturally resonant narratives, language, and elements into existing evidence-based strategies.

Study groups in NCT06337721
Study groupRoleWhat they receive
SPEARExperimentalThis arm will consist of the SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction) behavioral group intervention to reduce AUDs and alcohol-related harms in Pacific Islander young adults.
Receives: Behavioral: SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction)
ControlNo interventionThis control group arm will be compared to the SPEAR intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heavy Episodic Drinking (HED) Days

    # of Days of HED out of past 30 days

    Measured: Up to 30 weeks

Secondary outcomes (1)
  1. Alcohol Consumption

    7-day Alcohol Consumption

    Measured: Up to 30 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2024
  2. Study startSep 2024 (estimated)
  3. Primary completionMay 2028 (estimated)
  4. Study completionAug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Will conduct a randomized controlled trial of the SPEAR intervention vs. control group.
Masking
None (open label)
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06337721
Sponsor's protocol ID
R01AA030786
Status last verified
Mar 2024
First submitted
22 Mar 2024
Last updated
29 Mar 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing SPEAR (Strategies for Pacific Empowerment and Alcohol Reduction) in people with Alcohol Use Disorder and Alcohol; Harmful Use, run by University of California, Riverside at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact ANDREW SUBICA, Ph.D. ((951) 827-0200, asubica@medsch.ucr.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heavy Episodic Drinking (HED) Days (time frame: Up to 30 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in